Development of Targeted Nanomedicines via Machine Learning Processes
Licensed under
Category
Published on
Abstract
Nano WG February 21, 2019
Description: We are using data science to facilitate the development of nanoparticle drugs incorporating kinase inhibitors with diverse chemical structures. Doing this work inspired us to bring together the nanoinformatics community and to better understand how both data and information sciences can be used in nanomedicine and nanoparticle synthesis.
Cite this work
Researchers should cite this work as follows:
Submitter
National Cancer Institute